scholarly journals Non-hormonal therapy of patients with fibrocystic mastopathy in combination with endometrial hyperplasia

2022 ◽  
pp. 182-189
I. O. Borovikov ◽  
I. I. Kutsenko ◽  
V. P. Bulgakova ◽  
O. I. Borovikova

Introduction. The article presents a comparative analysis of the treatment of patients with combined estrogen-dependent pathology of female reproductive system: fibrocystic mastopathy and endometrial hyperplasia without atypia. The experience of treatment with an indole-carbinol-containing drug as monotherapy while using a levonorgestrel-releasing intrauterine system is presented.Aim. To evaluate the clinical efficacy of indolecarbinol in the treatment of patients with combined estrogen-dependent pathology of the female reproductive system.Materials and methods. The authors studied the responses to the treatment of patients with fibrocystic mastopathy and simple endometrial hyperplasia (n = 65) with the indole-carbinol-containing drug at a dose of 400 mg once daily for 12 months. All patients were divided into two groups: Group I (n = 32) – women who refused hormone therapy (indole-carbinol monotherapy); Group II (n = 33) – the use of indole-carbinol while using the levonorgestrel-releasing intrauterine system. Diagnostic methods: clinical and laboratory examination, ultrasound examination of mammary glands and pelvic organs, mammography, nipple discharge cytology at baseline and 6 and 12 months after the start of therapy. Before study group assignment to treatment, all patients underwent hysteroscopy with endometrial biopsy and histological examination. Descriptive statistics were used to evaluate the data: p-values below 0.05 were considered statistically significant.Results and discussion. The presented experience in treating women with combined pathology of the female reproductive system (fibrocystic mastopathy and endometrial hyperplasia without atypia) with the indole-carbinol-containing drug showed high clinical efficacy in mastopathy (relief of mastodynia (83.0 ± 1.6%), improvement of the ultrasound view of BI-RADS (66.1 ± 1.4%), reductions in mammographic density (66.1 ± 2.1%, p < 0.05)), high tolerability and satisfactory compliance. This drug combined with hormone therapy is recommended for the treatment of endometrial hyperplasia.Сonclusion. The use of indole-carbinol in the treatment of benign hyperplastic processes in mammary glands and endometrial hyperplasia is pathogenetically substantiated and shows high clinical efficacy

2020 ◽  
Vol XXV (149) ◽  
pp. 36-46
Elisandro O. dos Santos ◽  
Viviane Machado Pinto ◽  
Maria Inês Witz

Rabbits are among the most popular pets kept in the domestic environment, after dogs and cats. Therefore, more people have been seeking better information about their care, and finding greater availability of veterinarians qualified to treat these species. The result is increased longevity and more frequent diagnosis of various pathologies. Diseases that affect the female reproductive system such as neoplasias and hyperplasias are increasingly reported. In contrast, extra-uterine pregnancy is a disorder that is still poorly documented in rabbits in Brazil. The objective of this report is to describe a case of ectopic pregnancy with two fetuses in a 3-year-old rabbit, associated with endometrial hyperplasia succesfully treated by surgical intervention

2021 ◽  
pp. 120-127
Y. E. Dobrokhotova ◽  
M. R. Narimanova ◽  
L. V. Saprykina ◽  
I. Yu. Ilina ◽  
M. L. Mazo

Introduction. Amidst a steady increase in hyperplastic processes in uterus and mammary glands, numerous studies have shown that women with dyshormonal pathology of mammary glands had a range of gynecological diseases: external or internal endometriosis, hyperplastic processes of the endometrium and myometrium, polyps, polycystic ovary syndrome (PCOS), etc.Objective. To assess the mammary gland condition in premenopausal women with endometrial hyperplasia during indole-3-car-binol (I3C) therapy.Materials and methods. A total of 42 premenopausal patients aged 45-52 years (48.54 ± 1.83) were enrolled in an open-label prospective study. All patients received I3C 400 mg a day for 12 months. The examination included clinical laboratory, ultrasound imaging and mammographic examination of the mammary glands, cytologic examination of a nipple discharge. The examinations were carried out at the baseline, 6 and 12 months after starting treatment. The study findings were evaluated using descriptive statistics. Differences were considered significant at p <0.05.Results and discussion. All patients were diagnosed as having mastalgia before starting treatment. Mammary gland ultrasound imaging showed that the frequency of BI-RADS 2 was 9.5 times higher than that of BI-RADS 1 (90.5% and 9.5%, respectively, p <0.05). Mammography revealed that the frequency of BI-RADS 2 was 9.26 times higher than that of BI-RADS 1 (88% and 9.5%, respectively, p <0.05). After 6-month therapy, 59.5% of patients reported the disappearance of pain syndrome, the number of patients with ONE1/16a-ONE1 deviations decreased by 22%, 7.1% of patients showed improvement of ultrasound picture in BI-RADS. After 12-month therapy, the number of patients with ONE1 / 16a-ONE1 deviations decreased by 92.86% compared with the figures before starting treatment, ultrasound imaging showed improvement in the BI-RADS picture in 19% of patients, mammography findings - in 28.5% of patients. I3C is an effective and safe method to treat benign breast diseases in premenopausal women.Conclusion. Indole-3-carbinol therapy can be assessed as the treatment having an influence on the general components of pathogenesis of endometrial hyperplasia and benign hyperplastic processes in mammary glands. It is advisable to consider the use of indole-3-carbinol combined with antioxidant resveratrol in clinical practice.

2016 ◽  
pp. 30-32
V.A. Benyuk ◽  
D.M. Altibaeva ◽  
V.N. Goncharenko ◽  
V.V. Kurochka ◽  

The objective: to study the role of immunological mechanisms in the development of adenomyosis with endometrial hyperplasia in women of reproductive age and the phased introduction of an integrated hormonal and immunostimulating therapy. Patients and methods. The authors investigated the effect of hormone therapy on the immune system of women with adenomyosis and endometrial hyperplasia: We evaluated the influence of hormone therapy 135 women of reproductive age with adenomyosis in combination with endometrial hyperplasia: group i - 45 women using a progestogen (6 months); II – 45 women who took agonist of gonadotropin-relesing hormone (a-GnRH) (6 months) III – 45 women who received complex therapy involving a-GnRH during the first 6 months and immunomodulator intramuscularly every other day No. 20, with subsequent use of tablets of 0.15 g of 1 times a week (course – 6 months), then in the next 6 months was used progestogen in the second phase of the menstrual cycle from 16 to 25день. Evaluation of indicators of health status were performed after 3, 6 and 12 months of therapy. NK (natural killer) activity was estimated by the method of Hamaoka modification N.T. Rekowа. Results.We studied the role of immune system in the pathogenesis of adenomyosis, endometrial hyperplasia and endometrial and combined pathology of endo- and myometrium in women of reproductive age by assessing the cytotoxic activity of NK-cells, since this component determines its oversight role in the dynamics. Identified new pathogenic mechanisms in the development of benign pathology of the uterus due to the dysfunction of the immune system, especially expressed in terms of reduction of cytotoxic index of NK-cells. Conclusion. Developed a comprehensive phased hormone therapy for women of reproductive age with combined benign uterus pathology, including immunomodulator and the estimation of influence on parameters of immune status in the dynamics of observation. Key words: NK-cells, benign uterine pathology, comprehensive hormone therapy, Progestogens, -GnRH.

2019 ◽  
Vol 7 (23) ◽  
pp. 3925-3929
Anas A. Humadi ◽  
Bushra I. AL-Kaisei ◽  
Taghreed J. Humadai ◽  
Ali Ibrahim Ali AL-Ezzy

AIM: To determine toxicopathological and cytogenetic effects of Acetothioamide (ATA) on the female reproductive system. METHODS: Twenty albino female mice were divided equally into two groups: the first group (control) fed with diet pellet. The second group (treated) were inoculated intraperitoneally with a single dose of ATA (100 mg/kg Bw) for 15 days. All mice were sacrificed at the end of the experiment and blood was collected for evaluation of (FSH and LH), serum peroxy nitrate radical concentration. Cytogenetic analysis (chromosomal aberration, micronuclei, mitotic index and blast index) and the histopathological examination on ovary and uterus were done. RESULTS: ATA causes significant reduction (p < 0.0001) for FSH, LH and serum peroxy nitrate radical concentration among treated females. Oophoritis, pyometria, thrombosis and endometrial hyperplasia with granulomatous reaction were reported among treated females mainly in uterus tissue and ovary. CONCLUSION: ATA causes significant reduction for FSH, LH and serum peroxy nitrate concentration among treated females. Oophoritis, pyometria, thrombosis and endometrial hyperplasia with granulomatous reaction were the main pathological changes in uterus tissue and ovary among treated females.

Sam Chenery-Morris ◽  
Aileen Lynch

This chapter describes a number of clinical procedures related to the reproductive system that commonly occur in children. After completing this chapter you will have a working knowledge of the reproductive system and will have accomplished the following learning objectives. After reading this chapter you should be able to: ● Describe the anatomy of the female reproductive system including the external genitalia, the ovaries, the accessory reproductive structures, and the mammary glands. ● Describe the ovarian and menstrual cycles and the hormones that regulate them. ● Describe the anatomy of the male reproductive system including the external genitalia, the testes, the internal ducts, and the glands. ● Discuss the procedures involved in preparing the child for pelvic examination, demonstrating an awareness of the cultural, ethical, and legal implications of this examination. ● Explain and prepare the child for a swab procedure. ● Undertake the post-operative care of dressings on genitalia. Before embarking on this chapter it would be helpful to read through Chapter Two and Chapter Four, to provide you with relevant background skills required in this context. Informed consent and child protection are quite important related issues, and are covered in great detail in Chapter Four. The initial part of this chapter describes the anatomy and physiology of the reproductive system as a background towards understanding the relevant nursing care. This discussion is not intended to replace detailed study of anatomy and physiology, and for further and more detailed instruction on the topic you ought to consult a key text such as Martini & Nath (2008). The female reproductive system is regulated in a cyclical manner by hormones. The onset of the first menstrual cycle (menarche) occurs at puberty, and the female has the capacity to become pregnant up until the menopause, when the menstrual cycle ceases. The essential sex organs of the female reproductive system are the ovaries, which release one ovum (egg) each month. The fallopian tubes, uterus, vagina, and the mammary glands (breasts) make up the female accessory reproductive structures. The anatomy of the female reproductive system is illustrated in Figure 16.1.

1972 ◽  
Vol 70 (2) ◽  
pp. 396-408 ◽  
K.-D. Schulz ◽  
H. Haarmann ◽  
A. Harland

ABSTRACT The present investigation deals with the oestrogen-sensitivity of the female reproductive system during the neonatal period. Newborn female guinea pigs were used as test animals. At different times after a single subcutaneous injection of a physiological dose of 0.1 μg or an unphysiologically high dose of 10 μg 17β-oestradiol/100 g body weight, the RNA- and protein-synthesis was examined in the hypothalamic region, pituitary, cerebral cortex, liver, adrenal gland, ovary and uterus. With a physiological dose an increase in organ weight, protein content, RNA-and protein-synthesis was found only in the uterus. These alterations turned out to be dose-dependent. In addition to the findings in the uterus an inhibition of the aminoacid incorporation rate occurred in the liver following the injection of the high oestradiol dose. As early as 1 hour after the administration of 0.1 μg 17β-oestradiol an almost 100% increase in uterine protein synthesis was detectable. This result demonstrates a high oestrogen-sensitivity of this organ during the neonatal period. All the other organs of the female reproductive system such as the hypothalamus, pituitary and ovary did not show any oestrogen response. Therefore the functional immaturity of the uterus during post partem life is not the result of a deficient hormone sensitivity but is correlated with the absence of a sufficient hormonal stimulus at this time. The investigation on the effects of actinomycin resulted in different reactions in the uterus and liver. In contrast to the liver a paradoxical actinomycin effect was found in the uterus after treatment with actinomycin alone. This effect is characterized by a small inhibition of RNA-synthesis and a 50% increase in protein synthesis. The treatment of the newborn test animals with actinomycin and 17β-oestradiol together abolished the oestrogen-induced stimulation of the uterine RNA-and protein-synthesis. Consequently, the effect of oestrogens during the neonatal period is also connected with the formation of new proteins via an increased DNA-directed RNA-synthesis.

2017 ◽  
Vol 27 (3) ◽  
pp. 250-265 ◽  
Volodymyr Yu. Prokopyuk ◽  
Olga V. Grischenko ◽  
Oleksandra V. Prokopyuk ◽  
Nadiia O. Shevchenko ◽  

2020 ◽  
Vol 6 (1) ◽  
pp. 23-31
M. Alisherova ◽  
M. Ismailova

Currently, there are no standard approaches to monitoring patients with ovarian cancer (OC). While the role of ultrasound (US) has been identified in the primary diagnosis of OS, it is still controversial during the subsequent surgical treatment of OC. In world statistics, ovarian cancer is consistently among the four main localizations of malignant tumors of the female reproductive system, along with tumors of the breast, body and cervix.

Sign in / Sign up

Export Citation Format

Share Document